COVID-19和胃肠道:从病理生理学到临床表现
Filippo Vernia1, Hassan Ashktorab2, Nicola Cesaro1
1Gastroenterology Unit, Division of Gastroenterology, Hepatology, and Nutrition, Department of Life, Health and Environmental Sciences, University of L'Aquila, Piazzale Salvatore Tommasi 1, 67100 L'Aquila, Italy.
Medicina (Kaunas, Lithuania)
|October 28, 2023
概括
严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 直接感染胃肠道,导致腹和恶心等症状. 了解这种相互作用对于管理COVID-19至关重要,即使是接种疫苗.
科学领域:
- 胃肠病学 胃肠病学
- 病毒学 病毒学
- 传染性疾病 传染性疾病
背景情况:
- 由SARS-CoV-2引起的COVID-19流行病影响全球数百万人.
- 虽然主要是呼吸道,但COVID-19经常出现胃肠道症状.
- COVID-19的胃肠道表现需要进一步调查.
研究的目的:
- 审查胃肠道COVID-19的病理生理学.
- 概述胃肠道COVID-19的临床表现.
- 综合有关SARS-CoV-2胃肠道影响的当前知识.
主要方法:
- 系统的电子文献搜索到2023年1月.
- 搜索的数据库包括Medline,Scopus和科克兰图书馆.
- 专注于研究SARS-CoV-2在胃肠道中的作用.
主要成果:
- SARS-CoV-2 直接感染了胃肠道.
- 常见的症状包括腹,恶心,吐,腹痛,厌食症和味道变化.
- 病理变化包括粘膜损伤,炎症和改变的肠道微生物群.
- 目前正在研究克服胃酸的病毒机制.
结论:
- 尽管接种了疫苗,但可能会出现胃肠道症状,这表明潜在的长期病毒相互作用.
- 了解SARS-CoV-2的胃肠道影响对于患者管理至关重要.
- 需要进一步研究胃肠道SARS-CoV-2感染的长期后果.
更多相关视频
相关概念视频
Gastritis III: Clinical Manifestations and Management
292
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
292
Gastritis-II: Pathophysiology
348
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
348
Peptic Ulcer Disease II: Pathophysiology
468
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
468
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
138
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
138
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
325
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
325
Gastroesophageal Reflux Disease II: Clinical Features and Management
93
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
93


